Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
Prokineticin-2 (PK2) is a secreted protein involved in a number of physiological functions. Here, the authors find that PK2 expression increases in surviving DA neurons from Parkinson's disease patients, and show it protects against dopaminergic degeneration in PD mouse models.
Guardado en:
Autores principales: | Richard Gordon, Matthew L. Neal, Jie Luo, Monica R. Langley, Dilshan S. Harischandra, Nikhil Panicker, Adhithiya Charli, Huajun Jin, Vellareddy Anantharam, Trent M. Woodruff, Qun-Yong Zhou, Anumantha G. Kanthasamy, Arthi Kanthasamy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b8d6e03a18c04bd3a3c79b515e12e20f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury
por: Zhongyuan Bao, et al.
Publicado: (2021) -
Prokineticin receptor 2 affects GnRH3 neuron ontogeny but not fertility in zebrafish
por: Ivan Bassi, et al.
Publicado: (2020) -
Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation
por: Roberta Lattanzi, et al.
Publicado: (2021) -
PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons
por: Sarah J. Brown, et al.
Publicado: (2021) -
Prokineticin 1–prokineticin receptor 1 signaling in trophoblast promotes embryo implantation and placenta development
por: Ewelina Goryszewska-Szczurek, et al.
Publicado: (2021)